However, gemcitabine increased CD11b+Ly6Chigh cells infiltration in bladder cancer tissues (Mu et al., 2019) and lenvatinib was associated with increased tumor-infiltrating and circulating CD11b+Gr-1+ cells (Gunda et al., 2019). This evidence concerns the gene ITGAM and urinary bladder cancer.